Browsing: Rescheduling

The government spent most of its final brief making the legal case for Schedule III. Then, in the closing pages, it took the opposition’s witnesses apart,…

Every nongovernment participant selected for the DEA’s rescheduling hearing opposed reform. By the time the record closed, one marquee witness had undercut a central part of…

For months, the loudest opponents of rescheduling have called reform a corporate payday. In a July 2 filing defending rescheduling, the Justice Department told a federal…

A drug company spent nearly eight years fighting the DEA to make cannabis medicine the hard way. Now that everyone else is getting an easier path,…

The hearing that could decide weed’s federal future starts June 29. The DEA invited seven participants, and every one of them is against reform. It won’t…

This article originally appeared on IgniteIt and is republished here with permission. The Trump administration’s rescheduling order contains a little-noticed provision requiring the DEA to buy…

The Trump administration’s rescheduling order moved FDA-approved marijuana drug products and certain state-regulated medical marijuana products from Schedule I to Schedule III. But for Americans who…

On April 23, 2026, the Trump administration moved medical marijuana from Schedule I to Schedule III — the biggest federal cannabis policy shift in decades. It…

The Trump administration is preparing to move cannabis from Schedule I to Schedule III of the Controlled Substances Act as soon as today, according to reporting…

Trump just pushed out the attorney general he ordered to expedite marijuana rescheduling and replaced her, for now, with former personal lawyer Todd Blanche. Industry sources…